GlassScriptPhysician profile
Thomas J Maatman
NPI 1376501502
$10,056.64
in general payments reported to CMS, 2019-2025
42 companies · $1,144 in 2025
The $1,144 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,084 · 2020: $845 · 2021: $1,095 · 2022: $2,078 · 2023: $1,868 · 2024: $943 · 2025: $1,144.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,404 · Education: $550.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,404.19 |
| Education | $550.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,717.54 | 2019-2024 | Lithovue |
| Procept Biorobotics Corporation | $1,379.95 | 2020-2025 | Aquabeam Robotic System, Aquabeam System |
| Astellas Pharma US INC | $1,247.33 | 2019-2025 | Xtandi |
| Coloplast Corp | $594.14 | 2019-2025 | |
| Teleflex LLC | $400.55 | 2021-2025 | Urolift, Barrigel |
| Axonics, INC. | $390.29 | 2021-2022 | |
| Janssen Biotech, INC. | $331.80 | 2020-2025 | Erleada, Akeega, Carvykti |
| Olympus America INC. | $317.45 | 2019-2022 | |
| Neotract INC. | $283.03 | 2019-2020 | |
| Telix Pharmaceuticals | $263.97 | 2024-2025 | Illuccix |
| Dendreon Pharmaceuticals LLC | $245.88 | 2019 | |
| Blue Earth Diagnostics | $230.24 | 2019-2024 | |
| Intuitive Surgical, INC. | $213.17 | 2022-2025 | |
| Cook Medical LLC | $183.18 | 2019-2023 | Resonance |
| Medtronic USA, INC. | $177.88 | 2019-2020 |
Show all 42 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Photocure INC | $164.78 | 2021 | |
| Davol INC. | $160.00 | 2025 | Arista |
| Smith+Nephew, INC. | $149.33 | 2019-2020 | |
| Myovant Sciences INC. | $138.12 | 2021-2022 | |
| Medtronic, INC. | $134.46 | 2022 | |
| Pfizer INC. | $128.87 | 2019-2025 | |
| Laborie Medical Technologies Corp. | $117.58 | 2024-2025 | Optilume Bph Drug Coated Balloon Catheter |
| Endo USA, INC. | $117.47 | 2024-2025 | Xiaflex |
| Calyxo, INC. | $109.39 | 2025 | Cvac Aspiration System |
| Abbvie INC. | $94.26 | 2019-2025 | |
| Urogen Pharma, INC. | $93.78 | 2022 | |
| Conmed Corporation | $79.26 | 2023 | Visiclear, Conmed Specimen Retrieval, Airseal |
| Seagen INC. | $78.99 | 2025 | |
| Antares Pharma, INC. | $73.88 | 2019-2025 | Xyosted |
| Myriad Genetic Laboratories, INC. | $71.45 | 2021-2024 | Prolaris |
| Vertex Pharmaceuticals Incorporated | $55.85 | 2024-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $53.96 | 2019-2022 | |
| Tolmar, INC. | $50.88 | 2023 | |
| Allergan, INC. | $46.81 | 2019 | |
| Progenics Pharmaceuticals, INC. | $28.64 | 2023 | Pylarify |
| Ferring Pharmaceuticals INC. | $24.37 | 2024 | Adstiladrin |
| Novartis Pharmaceuticals Corporation | $22.25 | 2024 | |
| Halozyme INC | $19.50 | 2023 | |
| Astrazeneca Pharmaceuticals LP | $19.44 | 2025 | Onglyza |
| Immunitybio, INC. | $18.91 | 2025 | |
| Tolmar Pharmaceuticals, INC. | $15.07 | 2020 | |
| Merck Sharp & Dohme LLC | $12.94 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Maatman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.